A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability

Nature Genetics

Volumn 19, Issue 4, 1998, Pages 371-374

  Woitach, Joseph T ^a   Zhang, Minghuang ^a   Niu, Chien Hua ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; GENE DELETION; GENE REPRESSION; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; RETINOBLASTOMA; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CLONING, MOLECULAR; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; EPITHELIAL CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; ORGAN SPECIFICITY; RATS; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; XENOPUS PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 0031870964     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/1258     Document Type: Article

References (26)

1. Weinberg, R.A. Tumor suppressor genes. Science 254, 1138-1146 (1991).
2. Benedict, W.F. Patient with 13 chromosome deletion: evidence that the retinoblastoma gene is a recessive cancer gene. Science 219, 973-975 (1983).
3. Lee, E.Y. et al. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241, 218-221 (1988).
4. Horowitz, J.M. et al. Frequent inartivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl Acad. Sci. USA 87, 2775-2779 (1990).
5. Bookstein, R., Shew, J.Y., Chen, P.L., Scully, P. & Lee, W.H. Suppression of tumorigenicity human prostate carcinoma cells by replacing a mutated RB gene. Science 247, 712-715 (1990).
6. Yokota, J. et al. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene 3, 471-475 (1988).
7. Venter, D.J. et al. Retinoblastoma gene deletions in human glioblastomas. Oncogene 6, 445-448 (1991).
8. Cheng, J. et al. Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line. Blood 3, 730-735 (1990).
9. Huang, H.-J.S. et al. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242, 1563-1566 (1988).
10. Takahashi, R. et al. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc. Natl Acad. Sci. USA 88, 5257-5261 (1991).
11. Qin, X.-Q., Chittenden, T., Livingston, D.M. & Kaelin, W.G. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6, 953-964 (1992).
12. Goodrich, D.W., Wang, N.P., Qian, Y.W., Lee, E.Y. & Lee, W.H. The retinoblastoma gene product regulates progression through G1 phase of the cell cycle. Cell 67, 293-302 (1991).
13. Laiho, M., DeCaprio, J.A., Ludlow, J.W., Livingston, D.M. & Massague, J. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell 62, 175-185 (1990).
14. Zerfass, K. et al. Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7.1. Gen. Virol. 76, 1815-1820 (1995).
15. Huggett, A.C. et al. Development of resistance to the growth inhibitory effects of transforming growth factor beta 1 during the spontaneous transformation of rat liver epithelial cells. Cancer Res. 51, 5929-5936 (1991).
16. Barrack, E.R. TGF-beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 31, 61-70 (1997).
17. Padgett, R.W., Savage, C. & Das, P. Genetic and biochemical analysis of TGF beta signal transduction. Cytokine Growth Factor Rev. 8, 1-9 (1997).
18. Namba, M., Mihara, K. & Fushimi, K. Immortalization of human cells and its mechanisms. Crit Rev. Oncog. 7, 19-31 (1996).
19. Whyte, P. et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334, 124-129 (1988).
20. Lee, W.-H. et al. Human retinoblastoma susceptibility gene: cloning, identification and sequence. Science 235, 1394-1399 (1987).
21. Bernards, R. et al. Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc. Natl Aad. Sci. USA 86, 6474-6478 (1989).
22. Bruno, E. et al. The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. Blood 91, 1917-1923 (1998).
23. Altiok, A. Effect of transforming growth factor-beta 1 and -beta 2 on the proliferation of Burkitt lymphoma and lymphoblastoid cell lines. Growth Factors 4, 117-128 (1991).
24. Gryfe, R. et al. Molecular biology of colorectal cancer. Curr. Probl. Cancer 21, 233-300 (1997).
25. Piacibello, W., Severino, A., Stacchini, A. & Aglietta, M. Differential effect of transforming growth factor beta 1 on the proliferation of human lymphoid and myeloid leukemia cells. Haematologica 76, 460-466 (1991).
26. Garfield, S., Huber, B.E., Nagy, P., Cordingley, M.G. amp; Thorgeirsson, S.S. Neoplastic transformation and lineage switching of rat liver epithelial cells by retrovirusassociated oncogenes. Mol. Carcinog. 1, 189-195 (1988).